OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. Xu Z, Murad N, Malawsky D, Tao R, et al. Clin Cancer Res 2022 Jun 23:OF1-OF14. doi: 10.1158/1078-0432.CCR-22-0527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu Z, Murad N, Malawsky D, Tao R, et al. OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. Clin Cancer Res 2022 Jun 23:OF1-OF14. doi: 10.1158/1078-0432.CCR-22-0527.
PMID: 35736214